Fang J., Zou L., Zhou X. et al. Synonymous rare arginine codons and tRNA abundance affect protein production and quality of TEV protease variant . Plos One. 2014. (11). e112254.
Kapust R.B., Tozser J., Fox J.D. et al. Tobacco etch virus protease: Mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency . Prot. Eng. 2001. (12). 993-1000.
Karavaev V.S., Ryabchenko A.V., Beklemishev A.B. Evaluation of significance of Borrelia garinii spirochete recombinant protein DbpB for serodiagnostics of Ixodes tick-borne borreliosis . . Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of microbiology, epidemiology and immunobiology. 2013. (3). 73-79. [In Russian].
Karavaev V.S., Ryabchenko A.V., Beklemishev A.B. Immunochemical analysis of recombinant protein FlaA of West Siberian Borrelia garinii isolate . Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of microbiology, epidemiology and immunobiology. 2011. (4). 66-71. [In Russian].
Lucast L.J., Batey R.T., Doudna J.A. Large-scale purification of a stable form of recombinant tobacco etch virus protease . Biotechniques. 2001. (3). 544–546.
Nallamsetty S., Kapust, R.B., Tozser J. et al. Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro . Protein Expr. Purif. 2004. (1). 108-115.
Ryabchenko A.V., Karavaev V.S., Beklemishev A.B. Comparative structural and immunochemical analysis of recombinant OspC antigens of novosibirsk Borrelia garinii and Borrelia afzelii isolates . Byulleten' Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk = Bulletin of Siberian Branch of Russian Academy of Medical Sciences. 2010. (2). 6-12. [In Russian].
Ryabchenko A.V., Kotova M.V., Polyakov L.M. Designing superproducer of recombinant human apolipoprotein A-I based on Escherichia coli cells . Sibirskiy nauchnyy meditsinskiy zhurnal = Siberian scientific medical journal. 2015. (6). 16-21. [In Russian].
Sun C., Liang J., Shi R. et al. Tobacco etch virus protease retains its activity in various buffers and in the presence of diverse additives . Protein Expr. Purif. 2012. (1). 226-231.
Tropea J.E., Cherry S., Waugh D.S. Expression and purification of soluble his6-tagged TEV protease . High Throughput Protein Expression and Purification: Methods and Protocols. 2009. 297-307.
Van den Berg S., Lofdahl P., Hard T., et al. Improved solubility of TEV protease by directed evolution . J. Biotechnol. 2006. (3). 291–298.
Wei L., Cai X., Qi Z. et al. In vivo and in vitro characterization of TEV protease mutants . Protein Expr. Purif. 2012. (2). 157-163.
About Authors (Correspondence):
Ryabchenko A.V. – candidate of biological sciences, senior researcher of laboratory of medical biotechnology, e-mail: borrelia@mail.ru
Kotova M.V. – postgraduate student of laboratory of medical biotechnology, e-mail: zerokiri@mail.ru
Polyakov L.M. –doctor of medical sciences, professor, head of the laboratory of medical biotechnology, e-mail: plm@niibch.ru